Only the Lonely
August 2025
Aaron Gerds, MD
Dr. Gerds explores loneliness and burnout in medicine and reflects on the importance of community and connection in resolving these issues.
Skip Nav Destination
Editor's Corner
Menin Inhibitor Revumenib Yields Clinically Meaningful Responses in R/R NPM1-Mutated AML
August 2025
Treatment with the menin inhibitor revumenib yielded “clinically meaningful” responses in patients with relapsed or refractory acute myeloid leukemia (R/R AML) with an NPM1 mutation, according to phase II results from the AUGMENT-101 study.
Breakthrough Explores Innovation, Motivation Needed for Drug Development
August 2025
N. Nora Bennani, MD, reviews Breakthrough: The Quest for Life-Changing Medicines by William Pao, MD, PhD.
Half of Patients in EINSTEIN Jr. Trial Continue to Extended Anticoagulation Treatment
August 2025
Half of the children with venous thromboembolism opted to continue anticoagulation therapy after participating in the extended-phase anticoagulation cohort of the EINSTEIN Jr. phase III trial.
